Skip to content

Mantra meditation to improve wellbeing in urticaria patients attending St James’s Hospital

Attention-based training programme in the management of chronic spontaneous urticaria and angioedema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13672947
Enrollment
30
Registered
2020-09-22
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic spontaneous urticaria and angioedema Skin and Connective Tissue Diseases Urticaria

Interventions

This study has one arm, which is attendance at an attention-based training programme based on meditation for patients with chronic spontaneous urticaria. The attention-based training programme consist

Sponsors

St. James's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults with a clinical diagnosis of chronic spontaneous urticaria (CSU) with or without angioedema 2. Symptoms on at least one day per week 3. Urticaria control test score of <12 indicative of poorly controlled symptoms

Exclusion criteria

Exclusion criteria: 1. Patients who had started an anti-depressant medication in the past 3 months 2. Diagnosis of an Axis I mental health disorder

Design outcomes

Primary

MeasureTime frame
1. Barriers to implementation of the intervention identified through convergent interviewing techniques at baseline and 1-week post completion of the intervention 2. Recruitment and retention of participants measured by recording participant attendance throughout the intervention over an 8-week period 3. Adherence to daily practice using individual biofeedback tools (HeartMath software) throughout the intervention over an 8- week period 4. Feasibility of collecting outcome assessment data measured by assessing the return of data from participants at baseline and 1-week post completion of the intervention 5. Qualitative assessment of participant experiences of the programme collected via interview 1-week post completion of the intervention

Secondary

MeasureTime frame
1. Perceived individual symptoms measured using the urticaria control test (UCT) at baseline, 1 week before and 1 week after completion of the ABT programme 2. Depression, anxiety and stress measured using the depression-anxiety-stress score (DASS) at baseline and post 8-week ABT programme 3. Bio-psycho-social health measured using the PERMA-profiler at baseline, 1 week before and 1 week after completion of the ABT programme 4. Traits associated with sustained meditation practice (attention, observational skills, non-reactivity and non-judgemental skills) measured using the five-facet mindfulness questionnaire (FFMQ) at baseline, 1 week before and 1 week after completion of the ABT programme

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026